This inventor holds 1 USPTO granted patent. Top assignee: Amgen Research (Munich) Gmbh. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Christina Heitmueller: Innovator in Myeloid Leukemia Treatment
Introduction
Christina Heitmueller is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of myeloid leukemia. Her innovative approach has led to the development of a unique bispecific construct that holds promise for patients suffering from this challenging condition.
Latest Patents
Christina Heitmueller holds a patent for the "Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia." This invention provides a bispecific construct that includes a first binding domain specifically targeting CD33 and a second binding domain specifically targeting CD3. The method involves administering the construct for a maximum period of 14 days, followed by a period of at least 14 days without administration. This innovative approach aims to deliver a therapeutically efficient amount of the bispecific construct, contributing to the preparation of a pharmaceutical composition for treating myeloid leukemia.
Career Highlights
Christina is associated with Amgen Research (Munich) GmbH, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving treatment options for patients with myeloid leukemia. With her expertise and dedication, she has positioned herself as a key figure in the field of oncology research.
Collaborations
Christina collaborates with esteemed colleagues, including Peter Kufer and Marion Subklewe. These partnerships enhance her research efforts and contribute to the development of innovative treatment solutions.
Conclusion
Christina Heitmueller's contributions to the field of myeloid leukemia treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work at Amgen Research (Munich) GmbH and collaborations with other experts highlight her role as a leading inventor in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile